Prevalence of FLEDR and TRAELDT in patients with dcSSc divided by antibody status.

aadjusted standardized residual >1.96 indicates that the number of cases in that cell is significantly larger than would be expected if the null hypothesis were true (represented in bold), with a significance level of.05. An adjusted residual bwhen comparing different subgroups for FLEDR association: dcSSc ATA pos/dcSSc ATA neg/healthy controls: Fisher’s exact test p−6; dcSSc ATA pos/healthy controls: χ2 = 35.2, p−7; dcSSc ATA neg/healthy controls: not significant.cwhen comparing different subgroups for TRAELDT association: dcSSc ATA pos/dcSSc ATA neg/healthy controls: Fisher’s exact test p = 0.043; dcSSc ATA pos/healthy controls: χ2 = 9.4, p = 0.009; dcSSc ATA neg/healthy controls: not significant.